What is the appropriate management for a patient presenting with a headache?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Headache

Begin by immediately ruling out life-threatening secondary causes through targeted history and examination for red flags, then classify as primary versus secondary headache, and treat accordingly with evidence-based pharmacotherapy tailored to headache type and severity. 1, 2

Initial Assessment: Red Flags Requiring Urgent Investigation

The cornerstone is identifying patients who need immediate neuroimaging or further workup versus those with benign primary headache 3, 4:

Red Flags Mandating Urgent Evaluation

  • Thunderclap onset (pain peaking within 1 second to 1 minute) - consider subarachnoid hemorrhage 1, 5
  • Abrupt onset of severe headache - highest risk feature 1
  • Rapidly increasing frequency of headaches 1
  • Headache awakening patient from sleep 1
  • Focal neurologic signs or symptoms 1
  • History of uncoordination 1
  • Marked change in headache pattern 1
  • Persistent headache following head trauma 1
  • Headache worsened by Valsalva maneuver 1
  • New onset in patient >40-50 years old 1, 5
  • Fever with neck stiffness (meningitis) 2, 6
  • Presence of meningism, witnessed loss of consciousness, or limited neck flexion on exam 5

Neuroimaging Indications

Obtain CT head immediately if any red flags present; neuroimaging is NOT warranted for patients with normal neurologic examination and typical primary headache features meeting strict diagnostic criteria. 1

  • Consider neuroimaging for unexplained abnormal neurologic findings 1
  • If CT negative but subarachnoid hemorrhage suspected, proceed to lumbar puncture 7, 6

Classification of Primary Headaches

Once secondary causes excluded, classify using International Headache Society criteria 1:

Migraine Diagnostic Features (Need ≥2 of following)

  • Unilateral location 1
  • Throbbing character 1
  • Moderate to severe intensity 1
  • Worsening with routine activity 1

PLUS ≥1 of:

  • Nausea and/or vomiting 1
  • Photophobia and phonophobia 1

Tension-Type Headache Features (Need ≥2 of following)

  • Pressing, tightening, or nonpulsatile character 1
  • Mild to moderate intensity 1
  • Bilateral location 1
  • No aggravation with routine activity 1
  • No nausea/vomiting and no photophobia/phonophobia together (may have one) 1

Cluster Headache Features

  • Severe unilateral orbital, supraorbital, or temporal pain lasting 15-180 minutes 1
  • Ipsilateral autonomic features: lacrimation, nasal congestion, rhinorrhea, facial sweating, ptosis, miosis, eyelid edema 1
  • Frequency of 1-8 attacks per day 1

Treatment Algorithm by Headache Type and Severity

Mild to Moderate Migraine (First-Line)

Start with NSAIDs as first-line therapy, administered as early as possible during the attack. 1, 2

  • Naproxen sodium 500-825 mg at onset, repeat every 2-6 hours as needed (max 1.5g/day) 2
  • Ibuprofen 400-800 mg 2
  • Aspirin 900-1000 mg 2
  • Combination: aspirin + acetaminophen + caffeine (particularly effective) 1, 2

Add antiemetic 20-30 minutes before NSAID for synergistic analgesia: 2

  • Metoclopramide 10 mg PO 2
  • Prochlorperazine 25 mg PO 2

Moderate to Severe Migraine (First-Line)

Triptans are first-line for moderate-to-severe attacks or when NSAIDs fail. 2

Oral triptans with strong evidence: 2

  • Sumatriptan 50-100 mg
  • Rizatriptan 10 mg
  • Naratriptan 2.5 mg
  • Zolmitriptan 2.5-5 mg

For rapid onset or when nausea/vomiting present: 2

  • Subcutaneous sumatriptan 6 mg - most effective route, 59% pain-free at 2 hours, onset within 15 minutes 2
  • Intranasal sumatriptan 5-20 mg 2

Severe Migraine Requiring Parenteral Therapy

For ED/urgent care presentations, use IV combination therapy as first-line. 2

Recommended IV "Migraine Cocktail": 2

  • Metoclopramide 10 mg IV (provides direct analgesia, not just antiemetic effect) 2
  • Ketorolac 30 mg IV (or 60 mg IM if <65 years) - rapid onset, 6-hour duration, minimal rebound risk 1, 2
  • Prochlorperazine 10 mg IV - comparable efficacy to metoclopramide 2

Alternative parenteral options: 2

  • Dihydroergotamine (DHE) IV or intranasal - good efficacy and safety profile 2

Avoid in acute migraine management: 1, 2

  • Opioids (hydromorphone, meperidine) - lead to dependency, rebound headaches, loss of efficacy 1, 2
  • Prednisone/corticosteroids - limited evidence for acute treatment, more appropriate for status migrainosus 2
  • Diphenhydramine - not evidence-based for migraine 2

Tension-Type Headache Treatment

NSAIDs or acetaminophen are appropriate for tension-type headache. 1

  • Ibuprofen 400-600 mg 1
  • Naproxen 500 mg 1
  • Acetaminophen 1000 mg 1

Cluster Headache Treatment

Cluster headache requires specific rapid-acting therapy. 1

  • Subcutaneous sumatriptan 6 mg - most effective 2
  • High-flow oxygen 100% at 12-15 L/min for 15-20 minutes (standard of care, though not detailed in provided evidence)

Critical Medication-Overuse Headache Prevention

Limit ALL acute headache medications to no more than 2 days per week (or twice weekly) to prevent medication-overuse headache. 1, 2

Medications with High Rebound Risk

  • Opioids 1
  • Ergotamine 1
  • Triptans (when overused) 1
  • Analgesics (when overused) 1
  • Caffeine-containing combinations 2

If patient requires acute treatment >2 days/week, initiate preventive therapy immediately. 2

When Current Treatment Fails

If established migraine treatment stops working, follow this escalation algorithm: 2

  1. Rule out medication-overuse headache - most common cause of treatment failure 2
  2. Try different triptan - failure of one doesn't predict failure of others 2
  3. Optimize timing - ensure early administration while pain still mild 2
  4. Add combination therapy - triptan + fast-acting NSAID prevents 40% recurrence rate 2
  5. Change route - switch to subcutaneous if oral fails 2
  6. Initiate preventive therapy if using acute meds >2 days/week 2

Common Pitfalls to Avoid

  • Do NOT increase frequency of acute medications in response to treatment failure - this creates medication-overuse headache cycle 2
  • Do NOT use opioids as first-line - poor efficacy, high dependency risk 1, 2
  • Do NOT skip antiemetics - nausea itself is disabling and warrants treatment even without vomiting 2
  • Do NOT delay neuroimaging when red flags present - missing subarachnoid hemorrhage or meningitis has dire consequences 7, 5
  • Do NOT forget to refer to headache specialist after ED visit - lack of referral leads to high relapse and re-presentation rates 7

Contraindications and Cautions

Triptans contraindicated in: 2

  • Ischemic heart disease or previous MI
  • Uncontrolled hypertension
  • Significant cardiovascular disease

Ketorolac use with caution in: 2

  • Renal impairment (CrCl <30 mL/min)
  • History of GI bleeding
  • Heart disease

Metoclopramide contraindicated in: 2

  • Pheochromocytoma
  • Seizure disorder
  • GI bleeding or obstruction

Prochlorperazine additional risks: 2

  • Tardive dyskinesia
  • Hypotension, tachycardia, arrhythmias
  • Contraindicated with CNS depression or adrenergic blockers

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Headache Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute headache in the emergency department.

Handbook of clinical neurology, 2010

Research

Subarachnoid Hemorrhage and Headache.

Current pain and headache reports, 2019

Research

The headache in the Emergency Department.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.